Australian Prescriber

Many errors occur in the pre-analytical phase of laboratory testing, such as during patient preparation, sample collection, handling, storage and transport. Understanding how to minimise these errors is key to optimising the utility of laboratory tests.

Consensus-based lists of potentially inappropriate medicines outline medicines for which potential risks may outweigh the clinical benefits.

An overview of recent updates to aminoglycoside indications, dosing and monitoring in Australia.

Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective in treating pain and inflammation across a wide range of conditions. Choosing an NSAID requires an understanding of their different risk profiles in the context of individual patients.

COX-2 selective nonsteroidal anti-inflammatory drugs (NSAIDs), such as celecoxib, have an important role in managing dental pain.

Two new resources have been published that summarise tools to help health professionals support medicine management in people with multimorbidity and polypharmacy.

Momelotinib is a first-in-class oral treatment for adults with myelofibrosis, particularly those with anaemia or transfusion dependence.

Selpercatinib is an orally administered RET kinase inhibitor that provides a potential benefit over platinum-based chemotherapy for first- or second-line therapy for patients with RET fusion-positive NSCLC.